Prevalence and Co-Occurrence of Substance Use Disorders and Independent Mood and Anxiety Disorders

By B. Grant, F. Stinson, D. Dawson, S. Chou, M. Dufour, W. Compton, R. Pickering, K. Kaplan. Archives of General Psychiatry, 2004

1,893 citations recorded by the source corpus.

Background Uncertainties exist about the prevalence and comorbidity of substance use disorders and independent mood and anxiety disorders. Objective To present nationally representative data on the prevalence and comorbidity of Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM–IV) alcohol and drug use disorders and independent mood and anxiety disorders (including only those that are not substance induced and that are not due to a general medical condition). Design Face-to-face survey. Setting The United States. Participants Household and group quarters residents. Main Outcome Measures Prevalence and associations of substance use disorders and independent mood and anxiety disorders. Results The prevalences of 12-month DSM–IV independent mood and anxiety disorders in the U.S. population were 9.21 percent (95 percent confidence interval [CI], 8.78 percent–9.64 percent) and 11.08 percent (95 percent CI, 10.43 percent–11.73 percent), respectively. The rate of substance use disorders was 9.35 percent (95 percent CI, 8.86 percent–9.84 percent). Only a few individuals with mood or anxiety disorders were classified as having only substance-induced disorders. Associations between most substance use disorders and independent mood and anxiety disorders were positive and significant (p < .05). Conclusions Substance use disorders and mood and anxiety disorders that develop independently of intoxication and withdrawal are among the most prevalent psychiatric disorders in the United States. Associations between most substance use disorders and independent mood and anxiety disorders were overwhelmingly positive and significant, suggesting that treatment for a comorbid mood or anxiety disorder should not be withheld from individuals with substance use disorders.

Subfields: Cellular and Molecular Neuroscience, Epidemiology, Neurology

View Paper: https://www.semanticscholar.org/paper/3f0d66af9dfb8011619b04bfc035f242622bb147

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cellular and Molecular Neuroscience

In Epidemiology

In Neurology

Citations in the corpus

Addiction and the brain antireward system. (2008, result): “Recent data (Grant et al. 2004a–c) show similar results (21%–29% for mood disorders, 22%– 25% for anxiety, and 32%–70% for personality disorders).”
Alcohol: Effects on Neurobehavioral Functions and the Brain (2007, background): “Individuals who abuse alcohol or are alcoholdependent are considered to have alcohol use disorder (Grant et al. 2004).”
The depleted leader: The influence of leaders' diminished psychological resources on leadership behaviors ☆ ☆☆ (2014, neutral): “…and depression frequently co-occur (e.g., Belzer & Schneier, 2004; Gorman, 1997; Spitzer, Kreonke, Williams, & Lowe, 2006), and both anxiety (e.g. Grant et al., 2006; Swendsen et al., 1998) and depression (e.g. Gilman & Abraham, 2001; Grant & Harford, 1995) have been found to co-exist with…”
The Hierarchical Taxonomy of Psychopathology (HiTOP): A Dimensional Alternative to Traditional Nosologies (2017, positive): “…is very common in both clinical and community samples (Andrews, Slade, & Issakidis, 2002; Bijl, Ravelli, & van Zessen, 1998; Brown, Campbell, Lehman, Grisham, & Mancill, 2001; Grant et al., 2004; Kessler, Chiu, Demler, Merikangas, & Walters, 2005; Ormel et al., 2015; Teesson, Slade, & Mills, 2009).”